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Neutrophil granulocytes form the body’s first line of antibacterial defense, but they also contribute to tissue injury and
noninfectious, chronic inflammation. Proteinase 3 (PR3) and neutrophil elastase (NE) are 2 abundant neutrophil serine
proteases implicated in antimicrobial defense with overlapping and potentially redundant substrate specificity. Here, we
unraveled a cooperative role for PR3 and NE in neutrophil activation and noninfectious inflammation in vivo, which we
believe to be novel. Mice lacking both PR3 and NE demonstrated strongly diminished immune complex–mediated (IC-
mediated) neutrophil infiltration in vivo as well as reduced activation of isolated neutrophils by ICs in vitro. In contrast, in
mice lacking just NE, neutrophil recruitment to ICs was only marginally impaired. The defects in mice lacking both PR3
and NE were directly linked to the accumulation of antiinflammatory progranulin (PGRN). Both PR3 and NE cleaved
PGRN in vitro and during neutrophil activation and inflammation in vivo. Local administration of recombinant PGRN
potently inhibited neutrophilic inflammation in vivo, demonstrating that PGRN represents a crucial inflammation-
suppressing mediator. We conclude that PR3 and NE enhance neutrophil-dependent inflammation by eliminating the local
antiinflammatory activity of PGRN. Our results support the use of serine protease inhibitors as antiinflammatory agents.
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Neutrophils belong to the body’s first line of cellular defense and 
respond quickly to tissue injury and invading microorganisms (1). 
In a variety of human diseases, like autoimmune disorders, infec-
tions, or hypersensitivity reactions, the underlying pathogenic 
mechanism is the formation of antigen-antibody complexes, so-
called immune complexes (ICs), which trigger an inflammatory 
response by inducing the infiltration of neutrophils (2). The sub-
sequent stimulation of neutrophils by C3b-opsonized ICs results 
in the generation of ROS and the release of intracellularly stored 
proteases leading to tissue damage and inflammation (3). It is 
therefore important to identify the mechanisms that control the 
activation of infiltrating neutrophils.
Neutrophils abundantly express a unique set of neutrophil 
serine proteases (NSPs), namely cathepsin G (CG), proteinase 3 
(PR3; encoded by Prtn3), and neutrophil elastase (NE; encoded 
by Ela2), which are stored in the cytoplasmic, azurophilic gran-
ules. PR3 and NE are closely related enzymes, with overlapping 
and potentially redundant substrate specificities different from 
those of CG. All 3 NSPs are implicated in antimicrobial defense by 
degrading engulfed microorganisms inside the phagolysosomes of 
neutrophils (4–8). Among many other functions ascribed to these 
enzymes, PR3 and NE were also suggested to play a fundamental 
role in granulocyte development in the bone marrow (9–11).
While the vast majority of the enzymes is stored intracellular-
ly, minor quantities of PR3 and NE are externalized early dur-
ing neutrophil activation and remain bound to the cell surface, 
where they are protected against protease inhibitors (12, 13). 
These membrane presented proteases were suggested to act as 
path clearers for neutrophil migration by degrading components 
of the extracellular matrix (14). This notion has been addressed 
in a number of studies, which yielded conflicting results (15–17). 
Thus, the role of PR3 and NE in leukocyte extravasation and 
interstitial migration still remains controversial.
Emerging data suggest that externalized NSPs can contribute 
to inflammatory processes in a more complex way than by simple 
proteolytic tissue degradation (18). For instance, recent observa-
tions using mice double-deficient for CG and NE indicate that 
pericellular CG enhances IC-mediated neutrophil activation and 
inflammation by modulating integrin clustering on the neu-
trophil cell surface (19, 20). Because to our knowledge no Prtn3–/– 
mice have previously been generated, the role of this NSP in 
inflammatory processes has not been deciphered. Moreover, NE-
dependent functions that can be compensated by PR3 in Ela2–/– 
animals are still elusive.
Nonstandard	abbreviations	used: CG, cathepsin G; EBM, extravascular basement 
membrane; GRN, granulin; HPF, high-power field; IC, immune complex; MPO, 
myeloperoxidase; NE, neutrophil elastase; NSP, neutrophil serine protease; PGRN, 
progranulin; phox, phagocyte oxidase; PR3, proteinase 3; RPA, reverse passive Arthus 
reaction.
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One mechanism by which NSPs could upregulate the inflam-
matory response has recently been proposed. The ubiquitously 
expressed progranulin (PGRN) is a growth factor implicated in 
tissue regeneration, tumorigenesis, and inflammation (21–23). 
PGRN was previously shown to directly inhibit adhesion-depen-
dent neutrophil activation by suppressing the production of ROS 
and the release of neutrophil proteases in vitro (23). This antiin-
flammatory activity was degraded by NE-mediated proteolysis of 
PGRN to granulin (GRN) peptides (23). In contrast, GRN peptides 
may enhance inflammation (23) and have been detected in neu-
trophil-rich peritoneal exudates (24). In short, recent studies pro-
posed PGRN as a regulator of the innate immune response, but 
the factors that control PGRN function are still poorly defined 
and its relevance to inflammation needs to be elucidated in vivo.
In the present study, we generated double-deficient Prtn3–/–
Ela2–/– mice to investigate the role of these highly similar serine 
proteases in noninfectious neutrophilic inflammation. We estab-
lished that PR3 and NE are required for acute inflammation in 
response to subcutaneous IC formation. The proteases were found 
to be directly involved in early neutrophil activation events, because 
isolated Prtn3–/–Ela2–/– neutrophils were poorly activated by ICs in 
vitro. These defects in Prtn3–/–Ela2–/– mice were accompanied by 
accumulation of PGRN. We demonstrated that PGRN represents 
a potent inflammation-suppressing factor that is cleaved by both 
PR3 and NE. Our data delineate what we believe to be a previously 
unknown proinflammatory role for PR3 and NE, which is accom-
plished via the local inactivation of antiinflammatory PGRN.
Results
Generation of Prtn3–/–Ela2–/– mice. To analyze the role of PR3 and NE 
in neutrophilic inflammation, we generated a Prtn3–/–Ela2–/– mouse 
line by targeted gene disruption in embryonic stem cells (see Sup-
plemental Figure 1; supplemental material available online with 
this article; doi:10.1172/JCI34694DS1). Positive recombination of 
the Prtn3/Ela2 locus was proven by Southern blotting of embry-
onic stem cell clones (Figure 1A). Prtn3–/–Ela2–/– mice showed no 
expression of mRNA for PR3 and NE in bone marrow cells, as 
assessed by RT-PCR (Figure 1B). The successful elimination of 
PR3 and NE was confirmed at the level of proteolytic activity in 
neutrophil lysates using a PR3/NE-specific chromogenic substrate 
(Supplemental Figure 3) as well as by casein zymography (Figure 
1C). The substantially reduced casein degradation by heterozygous 
neutrophils indicates gene-dosage dependence of PR3/NE activi-
ties. Furthermore, PR3 and NE deficiency was proven by Western 
blotting using cell lysates from bone marrow–derived neutrophils, 
while other enzymes stored in azurophilic granula, such as CG 
and myeloperoxidase (MPO), were normally detected (Figure 1D). 
Crossing of heterozygous Prtn3+/–Ela2+/– mice resulted in regular 
offspring of WT, heterozygous, and homozygous genotype accord-
ing to the Mendelian ratio. Despite the absence of 2 abundant ser-
ine proteases, and in contrast to expectations based on previous 
reports (9–11), we found unchanged neutrophil morphology (Fig-
ure 1E) and regular neutrophil populations in the peripheral blood 
of the mutant mice, the latter as assessed via flow cytometry to 
determine the differentiation markers CD11b and Gr-1 (Figure 1F) 
Figure 1
Generation and characterization of Prtn3–/–Ela2–/– mice. (A) Southern blot showing the WT (+/+) 11.5-kb band of the nontargeted allele and the 
presence of an additional 7.5-kb band in a heterozygous (+/–) PR3/NE-targeted embryonic stem cell clone. (B) RT-PCR revealed the complete 
lack of mouse PR3 (mPR3; 437 bp) and mouse NE (743 bp) transcripts in bone marrow cells from Prtn3–/–Ela2–/– mice (–/–), while expression of 
β-actin (699 bp) was normal. (C) Casein zymography showed prominent casein degradative activity at 27 kDa in WT neutrophil lysates, while 
intermediate degradation by heterozygous lines and no degradation by Prtn3–/–Ela2–/– lines was found at this size. M, marker. (D) Western blot 
analysis of granule enzyme expression in bone marrow–derived neutrophils. In Prtn3–/–Ela2–/– neutrophils, no signals for PR3 and NE were 
detected, while CG (~26 kDa), MPO (~59 kDa), and a smaller degradation product of MPO were detected at the same levels as in WT neutro-
phils. (E) Microscopic analysis of H&E-stained blood smears revealed normal granulocyte morphology in Prtn3–/–Ela2–/– mice, with a polymor-
phic nucleus (dark blue) identical to that of WT neutrophils. Original magnification, ×20. (F) Flow cytometry of peripheral blood with gating on 
Gr-1hiCD11b+ showed regular neutrophil populations (boxed regions) in Prtn3–/–Ela2–/– mice. Plots are representative of data obtained from 3 
mice per group. Percentages denote percent cells in the boxed regions.
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(25, 26). Moreover, Prtn3–/–Ela2–/– mice demonstrated normal per-
centages of the leukocyte subpopulations in the peripheral blood, 
as determined by the Diff-Quick staining protocol and by hemo-
cytometric counting (Supplemental Figure 2, A and B). Hence, the 
proteases are not crucially involved in granulopoiesis, and ablating 
PR3 and NE in the germ line represents a valid approach to assess 
their biological significance in vivo.
PR3 and NE are dispensable for neutrophil extravasation and inter-
stitial migration. To examine neutrophil infiltration into the 
perivascular tissue, we applied phorbol esters (croton oil) to the 
mouse ears. At 4 h after stimulation, we assessed the neutrophil 
distribution in relation to the extravascular basement membrane 
(EBM) by immunofluorescence microscopy of fixed whole-mount 
specimens (Figure 2A). We found that Prtn3–/–Ela2–/– neutrophils 
transmigrated into the interstitium without retention at the EBM 
(Figure 2B), resulting in quantitatively normal and widespread 
neutrophil influx compared with WT mice (Figure 2C). More-
over, we analyzed chemotactic migration of isolated neutrophils 
through a 3-dimensional collagen meshwork in vitro (Supple-
mental Video 1) and found unhampered chemotaxis toward a 
C5a gradient, based on the directionality (Figure 2D) and velocity 
(Figure 2E) of Prtn3–/–Ela2–/– neutrophils. These findings led us to 
conclude that PR3 and NE are not principally required for neutro-
phil extravasation or interstitial migration.
Reduced inflammatory response to ICs in Prtn3–/–Ela2–/– mice. The 
formation of ICs represents an important trigger of neutrophil-
dependent inflammation in many human diseases (2). To deter-
mine the role of PR3 and NE in this context, we induced a classic 
model of subcutaneous IC-mediated inflammation, namely the 
reverse passive Arthus reaction (RPA) (27). At 4 h after RPA induc-
tion, we assessed the cellular inflammatory infiltrates by histology 
using H&E-stained skin sections (Figure 3A). Neutrophils, which 
were additionally identified by Gr-1 immunohistochemistry, 
made up the vast majority of all cellular infiltrates (Figure 3A). 
We found that neutrophil infiltration to the sites of IC formation 
was severely diminished in Prtn3–/–Ela2–/– mice. Indeed, histologi-
cal quantification revealed significantly reduced neutrophil influx 
in Prtn3–/–Ela2–/– mice compared with WT mice, while Ela2–/– mice 
Figure 2
PR3 and NE are not principally required for neutrophil extravasation and interstitial migration. (A and B) Phorbol ester–treated ear tissues of 
WT and Prtn3–/–Ela2–/– mice were immunostained for laminin (LN; green) to visualize EBM and Gr-1 (red) to identify neutrophils. Lesions were 
examined 4 h after stimulus application by fluorescence microscopy as described in Methods. (A) Representative images of tissue from WT and 
Prtn3–/–Ela2–/– mice. Both genotypes developed strong and widespread neutrophil infiltrations. (B) Higher-magnification images of boxed regions 
in A. Prtn3–/–Ela2–/– neutrophils showed no retention at the EBM. Scale bars: 200 μm (A); 25 μm (B). (C) Overall neutrophil infiltrates were quanti-
fied as the percentage of Gr-1–positive cells per microscopic field. Data are mean ± SEM. Intravascular cells were excluded. No significant differ-
ence between WT and Prtn3–/–Ela2–/– mice was found (P = 0.63). In vitro migration of WT and Prtn3–/–Ela2–/– neutrophils directed by C5a through 
3-dimensional collagen matrices was analyzed by time-lapse video microscopy (see Supplemental Video 1). (D) The tracks of WT (n = 41) 
and Prtn3–/–Ela2–/– (n = 42) neutrophils are shown, and the factor for directionality ± SEM is indicated. No impairment was observed regarding 
chemotactic directionality of Prtn3–/–Ela2–/– versus WT neutrophils (P = 0.19). (E) Velocities of single cells (individual points) were calculated and 
averaged (red bar). Prtn3–/–Ela2–/– neutrophils showed no significant difference versus WT cells (P = 0.30).
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showed marginally reduced neutrophil counts (Figure 3B). These 
results indicate that PR3 and NE fulfill an important proinflam-
matory function during IC-mediated inflammation.
PR3 and NE enhance neutrophil activation by ICs in vitro. Because PR3 
and NE were required for the inflammatory response to IC (Figure 
3), but not to phorbol esters (Figure 2), we considered the enzymes 
as enhancers of the neutrophil response to IC. We therefore assessed 
the oxidative burst using dihydrorhodamine as a readout for cellular 
activation of isolated, TNF-α–primed neutrophils in the presence of 
ICs in vitro. While both WT and Prtn3–/–Ela2–/– neutrophils showed 
a similar, approximately 20-min lag phase before the oxidative burst 
commenced, the ROS production over time was markedly reduced, 
by 30%–40%, in the absence of PR3 and NE (Figure 4A). In contrast, 
oxidative burst triggered by 25 nM PMA was not hindered in Prtn3–/–
Ela2–/– neutrophils (Figure 4B), which indicated no general defect in 
producing ROS. We also performed a titration series ranging from 
0.1 to 50 nM PMA and found no reduction in oxidative burst activ-
ity in Prtn3–/–Ela2–/– neutrophils at any PMA concentration used 
(Supplemental Figure 4). These data are consistent with our in vivo 
experiments showing that neutrophil influx to ICs was impaired 
(Figure 3), whereas the inflammatory response to phorbol esters was 
normal (Figure 2, A–C), in Prtn3–/–Ela2–/– mice. To compare neutro-
phil priming in WT and Prtn3–/–Ela2–/– neutrophils, we analyzed cell 
surface expression of CD11b after 30 min of incubation at various 
concentrations of TNF-α and found no difference (Supplemental 
Figure 5). Moreover, we observed normal neutrophil adhesion to IC-
coated surfaces (Supplemental Figure 6A) and unaltered phagocyto-
sis of opsonized, fluorescently labeled E. coli bacteria (Supplemental 
Figure 6, B and C) in the absence of both proteases. We therefore 
hypothesized that PR3 and NE enhance early events of adhesion-
dependent neutrophil activation after TNF-α priming and binding 
of ICs. It is important to note that Ela2–/– neutrophils were previ-
ously shown to react normally in the same setup (20). Regarding the 
highly similar cleavage specificities of both proteases, we suggested 
that PR3 and NE complemented each other during the process of 
neutrophil activation and inflammation.
Antiinflammatory PGRN is degraded by PR3 and NE during IC-medi-
ated neutrophil activation. This reasoning prompted us to search for 
substrates that are processed by both PR3 and NE and are thereby 
able to enhance neutrophilic activation. In a previous study, PGRN 
was described as a potent inhibitor of the adhesion-dependent oxi-
dative burst of human TNF-α–primed neutrophils in vitro, which 
can be inactivated by NE (23). Because we observed a substantial 
reduction in ROS production in Prtn3–/–Ela2–/– neutrophils com-
pared with WT cells (Figure 4A), we evaluated a potential link 
between PGRN cleavage and oxidative burst of neutrophils activat-
ed by ICs. We analyzed the culture supernatant as well as the cel-
lular pellet of IC-activated neutrophils for the presence of PGRN 
by IB (Figure 4C). Indeed, the inhibitory, intact form of PGRN was 
detected in the supernatant of Prtn3–/–Ela2–/– neutrophils only. We 
also found a cellular pool of PGRN in all genotypes that was more 
abundant in Prtn3–/–Ela2–/– cells than in WT or Ela2–/– neutrophils. 
This led us to conclude that PGRN was released and degraded by 
PR3 and NE during neutrophil activation.
PGRN inhibits neutrophil activation by ICs in vitro. To show that the 
reduced oxidative burst of Prtn3–/–Ela2–/– neutrophils can be caused 
by defective PGRN degradation, we evaluated the amount of cell-
associated and secreted PGRN detected by IB (Figure 4C). We tested 
whether these concentrations inhibited the IC-mediated oxidative 
burst of WT neutrophils when added to the cells in vitro. Indeed, 
when 100 nM PGRN was applied to WT granulocytes activated by 
ICs, the ROS response markedly decreased (Figure 4D). In positive 
control experiments, activation of neutrophils was unaffected by 
PGRN application when they were stimulated with PMA (Figure 
4E). These data endorse the inhibitory effect of intact PGRN on 
innate immune cell activation and prove that defective PGRN deg-
radation may cause the reduced activation and oxidative burst of 
Prtn3–/–Ela2–/– neutrophils triggered by ICs.
Both PR3 and NE process PGRN in vitro. In previous studies, NE 
was proposed as the principal PGRN-converting protease (23). 
Our experiments revealed an equally important role of PR3 in 
this pathway, because Ela2–/– neutrophils were not impaired in 
Figure 3
Impaired inflammatory response to locally formed ICs in Prtn3–/–Ela2–/– mice. (A) Representative photomicrographs of inflamed skin sections 4 h 
after IC formation. Neutrophils were identified morphologically (polymorphic nucleus) in H&E stainings and by Gr-1 staining (red). The cellular 
infiltrates were located to the adipose tissue next to the panniculus carnosus muscle (asterisks) and were primarily composed of neutrophil 
granulocytes. Scale bars: 200 μm. (B) Neutrophil infiltrates in lesions from Prtn3–/–Ela2–/– mice were significantly diminished compared with 
Ela2–/– mice and WT mice. Neutrophil influx in Ela2–/– mice was slightly, but not significantly, diminished compared with WT mice. Results are 
mean ± SEM infiltrated neutrophils per HPF. *P < 0.05.
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their degradation of PGRN (Figure 4C). We further substantiated 
this concept by incubating recombinant PGRN with the purified 
proteases in vitro. Both enzymes completely degraded PGRN as 
early as 5 min after incubation, although the pattern of lower–
molecular weight cleavage products analyzed by silver-stained 
SDS-PAGE was not identical for both proteases (Figure 5, A and 
B). Hence, both PR3 and NE are potent converters of PGRN, indi-
cating biological redundancy of the proteases in this process.
PR3 and NE are major PGRN-degrading enzymes of neutrophils. To eval-
uate the significance of PR3 and NE as PGRN-degrading enzymes, 
we next incubated recombinant mouse PGRN with neutrophil 
lysates from WT and protease-deficient mice. Anti-PGRN Western 
blot revealed that PGRN degradation was minimally reduced in the 
absence of NE, but strongly impaired when both PR3 and NE were 
lacking (Figure 5C). This observation demonstrates that PR3 and 
NE are major PGRN-converting enzymes of neutrophils, a finding 
supported by previous experiments showing that CG, the third 
NSP of primary granules, does not cleave PGRN (23).
PGRN inhibits IC-mediated inflammation in vivo. To provide in vivo evi-
dence for the relevance of PGRN as an antiinflammatory mediator, 
we administered 2 μg recombinant PGRN to IC-mediated inflam-
mation in mice. PGRN-treated lesions were directly compared with 
untreated lesions in the same mouse (Figure 6A). In both WT and 
Prtn3–/–Ela2–/– mice, neutrophil accumulation was diminished at the 
PGRN-treated sites of IC-mediated inflammation, demonstrating 
that PGRN is a crucial inhibitory factor for neutrophilic inflam-
mation. Neutrophil infiltration was reduced to a greater extent 
in Prtn3–/–Ela2–/– (40% reduction, P < 0.01; Figure 6C) than in WT 
mice (25% reduction, P < 0.05; Figure 6B), which likely reflected the 
impact of the PGRN-degrading proteases in this pathway.
PR3 and NE cleave PGRN during inflammation in vivo. Finally, we 
aimed to demonstrate defective PGRN degradation in Prtn3–/–Ela2–/– 
mice during neutrophilic inflammation in vivo. For practical 
reasons, we harvested infiltrated neutrophils from the inflamed 
peritoneum 4 h after casein injection and subjected the lysates of 
these cells to anti-PGRN Western blot. Intact, inhibitory PGRN 
was detected in Prtn3–/–Ela2–/– neutrophils, but not in WT cells 
(Figure 6D). These data prove that neutrophilic inflammation is 
accompanied by proteolytic removal of antiinflammatory PGRN 
and that the process of PGRN degradation is essentially impaired 
in vivo in the absence of PR3 and NE.
Discussion
Chronic inflammatory and autoimmune diseases are often per-
petuated by continuous neutrophil infiltration and activation. 
According to the current view, the role of NSPs in these diseases is 
mainly associated with proteolytic tissue degradation after their 
release from activated or dying neutrophils. However, recent obser-
Figure 4
Impaired oxidative burst and PGRN degradation by IC-activated Prtn3–/–Ela2–/– neutrophils. Oxidative burst as the readout for neutrophil activa-
tion by ICs was measured over time. (A) While no difference was observed during the initial 20-min lag phase of the oxidative burst, Prtn3–/–
Ela2–/– neutrophils exhibited diminished ROS production over time compared with WT neutrophils. (B) Bypassing receptor-mediated activation 
using 25 nM PMA restored the diminished oxidative burst of Prtn3–/–Ela2–/– neutrophils. Results are presented as normalized fluorescence in AU 
(relative to maximum fluorescence produced by WT cells). Data (mean ± SD) are representative of 3 independent experiments each conducted 
in triplicate. (C) Isolated mouse neutrophils were activated by ICs in vitro and tested for PGRN degradation by IB. In the cellular fraction, the 
PGRN (~80 kDa) signal was markedly increased in Prtn3–/–Ela2–/– cells compared with WT and Ela2–/– neutrophils. Intact PGRN was present in 
the supernatant (SN) of IC-activated Prtn3–/–Ela2–/– neutrophils only, not of WT or Ela2–/– cells. (D and E) Exogenous administration of 100 nM 
PGRN significantly reduced ROS production of neutrophils activated by ICs (D), but not when activated by PMA (E). Data (mean ± SD) are 
representative of 3 independent experiments each conducted in triplicate.
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vations suggest that NSPs such as CG may contribute to nonin-
fectious diseases in a more complex manner, namely as specific 
regulators of inflammation (18). Here, we demonstrate that PR3 
and NE cooperatively fulfilled an important proinflammatory role 
during neutrophilic inflammation. PR3 and NE directly enhanced 
neutrophil activation by degrading oxidative burst–suppressing 
PGRN. These findings support the use of specific serine protease 
inhibitors as antiinflammatory agents.
Much attention has been paid to the degradation of extracellular 
matrix components by NSPs. We therefore expected that ablation 
of both PR3 and NE would cause impaired neutrophil extrava-
sation and interstitial migration. Surprisingly, we found that 
the proteases were principally dispensable for these processes: 
Prtn3–/–Ela2–/– neutrophils migrated normally through a dense, 
3-dimensional collagen matrix in vitro and demonstrated regular 
extravasation in vivo when phorbol esters were applied (Figure 2). 
This finding is in agreement with recent reports that neutrophils 
preferentially and readily cross the EBM through regions of low 
matrix density in the absence of NE (28).
Conversely, we observed that PR3 and NE were required for the 
inflammatory response to locally formed ICs (Figure 3). Even iso-
lated Prtn3–/–Ela2–/– neutrophils were challenged in performing 
oxidative burst after IC stimulation in vitro (Figure 4A), showing 
that the proteases directly enhanced the activation of neutrophils 
also in the absence of extracellular matrix. However, when recep-
tor-mediated signal transduction was bypassed by means of PMA, 
neutrophils from Prtn3–/–Ela2–/– mice performed normal oxidative 
burst (Figure 4B), indicating that the function of the phagocyte 
oxidase (phox) complex was not altered in the absence of PR3 and 
NE. These findings substantiate what we believe to be a novel para-
digm: that all 3 serine proteases of azurophilic granules (CG, PR3, 
and NE), after their release in response to IC encounter, potentiate 
a positive autocrine feedback on neutrophil activation.
In contrast to CG, the highly related proteases PR3 and NE coop-
erate in the effacement of antiinflammatory PGRN, leading to 
enhanced neutrophil activation. Previous studies already demon-
strated that PGRN is a potent inhibitor of the adhesion-dependent 
oxidative burst of neutrophils in vitro, which can be degraded by NE 
(23). Here, we showed that PR3 and NE play an equally important role 
in the regulation of PGRN function. 
Ela2–/– neutrophils were sufficiently 
able to degrade PGRN. Only in the 
absence of both PR3 and NE was 
PGRN degradation substantially 
impaired, resulting in the accumu-
lation of antiinflammatory PGRN 
during neutrophil activation in 
vitro (Figure 4C) and neutrophilic 
inflammation in vivo (Figure 6D). 
Moreover, we provided in vivo evi-
dence for the crucial role of PGRN 
as an inflammation-suppressing 
mediator, because administration 
of recombinant PGRN potently 
inhibited the neutrophil influx 
to sites of IC formation (Figure 6, 
A–C). Hence, the cooperative degra-
dation of PGRN by PR3 and NE is a 
decisive step for the establishment 
of neutrophilic inflammation.
The molecular mechanism of PGRN function is not yet completely 
understood, but it seems to interfere with integrin (CD11b/CD18) 
outside-in signaling by blocking the function of pyk2 and thus 
dampens adhesion-related oxidative burst even when added after 
the initial lag phase of oxidase activation (23). PGRN is produced by 
neutrophils and stored in highly mobile secretory granules (29). It 
was recently shown that PGRN can bind to heparan-sulfated proteo-
glycans (30), which are abundant components of the EBM and vari-
ous cell surfaces, including those of neutrophils. Also, PR3 and NE 
are known to interact with heparan sulfates on the outer membrane 
of neutrophils, where the enzymes appear to be protected against 
protease inhibitors (12, 13, 31). These circumstantial observations 
support the notion that PGRN cleavage by PR3 and NE takes place at 
the pericellular microenvironment of the neutrophil cell surface.
Impaired outside-in signaling most likely reduced the oxidative 
burst in Prtn3–/–Ela2–/– neutrophils adhering to ICs. In support of 
this hypothesis, we excluded an altered response to TNF-α prim-
ing (Supplemental Figure 5) as well as reduced adhesion to immo-
bilized ICs and defective endocytosis of serum-opsonized E. coli in 
Prtn3–/–Ela2–/– neutrophils (Supplemental Figure 6). MPO content 
and processing was also unchanged in Prtn3–/–Ela2–/– neutrophils 
(Figure 1D); hence, the previously discussed inhibitory effect of 
MPO on phox activity (32, 33) does not appear to be stronger in 
neutrophils lacking PR3 and NE. Because there was no difference 
in the lag phase of the oxidative burst, initial IC-triggered receptor 
activation was probably not affected by either PRGN or PR3/NE. 
Our concept is consistent with all these observations and takes 
into account that PGRN unfolds its suppressing effects in the 
second phase, when additional membrane receptors, endogenous 
PGRN, and some PR3/NE from highly mobile intracellular pools 
are translocated to the cell surface. The decline and cessation of 
ROS production suggested to us that outside-in signaling was 
not sustained and that active oxidase complexes were no longer 
replenished in the absence of PR3 and NE. Our present findings, 
however, do not allow us to exclude other potential mechanisms, 
such as accelerated disassembly of the active oxidase complex.
During cutaneous inflammation, PGRN is provided by multiple 
sources, including skin cells and neutrophils themselves, which 
produce and release PGRN as they infiltrate the tissue (21, 29). 
Figure 5
PR3 and NE are major PGRN processing enzymes of neutrophils. (A and B) Silver-stained SDS-PAGE 
analysis of recombinant human PGRN incubated at a 1:10 enzyme/substrate ratio with purified human 
NE (A) and recombinant mouse PR3 (B). Both NE and PR3 completely cleaved ~80-kDa PGRN to small-
er molecular fragments within 5 min of incubation. (C) Recombinant mouse PGRN was incubated with 
neutrophil lysates from WT, Ela2–/–, and Prtn3–/–Ela2–/– mice for 1 h at 37°C and analyzed by anti-mouse 
PGRN Western blot. Compared with untreated PGRN (control), WT neutrophils completely degraded 
PGRN. In Ela2–/– neutrophils, a faint band of intact PGRN was detected, while in Prtn3–/–Ela2–/– neutro-
phils, a distinct PGRN band remained, comparable to control.
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Thus, PGRN represents a prominent factor to control extravascu-
lar neutrophil function during skin inflammation. Proteolytic pro-
cessing of PGRN was previously shown to generate GRN peptides 
that accumulate in inflammatory exudates, such as during casein-
induced peritonitis (34). In contrast to the precursor PGRN, these 
GRN peptides might be proinflammatory and induce the release of 
neutrophil-attracting IL-8 from epithelial cells (23). In the absence 
of PR3 and NE, neutrophils are no longer able to provide the switch 
from inflammation-suppressing PGRN to proinflammatory GRN 
peptides. The activation of neutrophils by ICs is a decisive event in 
the cascade of reactions during the RPA. IC-activated neutrophils 
are known to release cytokines and chemokines and thus establish 
an inflammatory milieu. We hypothesize that the local persistence 
of PGRN dampens neutrophil activation and release of ROS as well 
as other inflammatory mediators in response to ICs, which results 
in diminished recruitment of further neutrophils in Prtn3–/–Ela2–/– 
mice. Hence, defective PGRN degradation can account for the 
impaired inflammation in the absence of PR3 and NE (Figure 7).
NSPs are strongly implicated as effector molecules in a large 
number of destructive diseases, such as emphysema or the autoim-
mune blistering skin disease bullous pemphigoid (14, 35–37). Nor-
mally, PR3/NE activity is tightly controlled by high plasma levels of 
α1-antitrypsin. This balance between proteases and protease inhibi-
tors is disrupted in patients with genetic α1-antitrypsin deficiency, 
which represents a high risk factor for the development of emphyse-
ma and certain autoimmune disorders (38). The pathogenic effects 
of NSPs in these diseases have so far been associated with tissue 
destruction by the proteases after their release from dying neutro-
phils. Our findings showed that PR3 and NE were already involved 
in much earlier events of the inflammatory process, because the 
enzymes directly regulated cellular activation of infiltrating neutro-
phils by degrading inflammation-suppressing PGRN. This concept 
is further supported by previous studies showing increased inflam-
mation in mice lacking serine protease inhibitors such as SERPINB1 
or SLPI (39, 40). Blocking PR3/NE activity using specific inhibitors 
therefore represents a promising therapeutic strategy to treat chron-
ic, noninfectious inflammation. Serine protease inhibitors as anti-
inflammatory agents can interfere with the disease process at 2 dif-
ferent stages, because they attenuate both early events of neutrophil 
activation and proteolytic tissue injury caused by released NSPs.
Methods
Mice. Simultaneous deficiency of the Prtn3 and Ela2 gene cluster in 
129S6/SvEv mice was generated by homologous recombination in embry-
onic stem cells as detailed in Supplemental Methods. Ela2–/– mice on the 
129S6/SvEv genetic background were previously generated (41) and were 
obtained as frozen embryos from the Medical Research Council Harwell 
(Oxford, United Kingdom). These and WT control mice were kept under 
pathogen-free conditions at the GSF Neuherberg (Munich, Germany). For 
most experiments, mice at 5–8 weeks of age were used. All animal experi-
ments were performed with approval by the District Government of Upper 
Bavaria (Munich, Germany).
Characterization of Prtn3–/–Ela2–/– mice. We analyzed the caseinolytic activity of 
neutrophil lysates from WT Prtn3+/+Ela2+/+ mice, heterozygous Prtn3+/–Ela2+/– 
mice, and homozygous Prtn3–/–Ela2–/– mice by casein zymography. In short, 
1.5 mg/ml casein (Sigma-Aldrich) was added to SDS polyacrylamide gels, and 
the lysate of 2.5 × 105 cells per well was separated under nonreducing condi-
tions at 4°C. Gels were then washed in PBS with 2.5% Triton X-100 followed 
by incubation overnight in Tris/HCl (pH 7.4), 10 mM CaCl2, and 0.02% Brij 35. 
Gels were washed, stained with Coomassie blue, and destained in acetic acid.
Figure 6
PGRN is a potent inhibitor of IC-stimulated inflammation in vivo. Recombinant mouse PGRN (2 μg) was intradermally applied with anti-OVA 
IgG, and the RPA was started in WT and Prtn3–/–Ela2–/– mice (n = 5 per group). (A) After 4 h, the effect of PGRN application was evaluated by 
histological analyses. Representative images show neutrophil infiltrates at the panniculus carnosus muscle (asterisks). Scale bars: 200 μm. (B 
and C) Effect of PGRN administration on neutrophil influx. In both WT (B) and Prtn3–/–Ela2–/– (C) mice, neutrophil infiltration was significantly 
diminished at PGRN-treated sites compared with untreated sites. This effect appeared to be more pronounced in the protease-deficient mice. 
Data are mean ± SEM infiltrated neutrophils per HPF. *P < 0.05; **P < 0.01. (D) Neutrophils isolated ex vivo from inflamed peritoneum of WT and 
Prtn3–/–Ela2–/– mice were analyzed by anti-mouse PGRN Western blot of concentrated neutrophil lysates. Intact PGRN was found abundantly in 
Prtn3–/–Ela2–/– but not WT neutrophils. Loading was controlled using anti-actin Western blot.
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To confirm the successful and specific knockout of PR3 and NE, we per-
formed Western blot analyses of bone marrow–derived neutrophils. After 
reducing SDS-PAGE of neutrophil lysates and electrotransfer onto nitrocel-
lulose, we probed the membranes with polyclonal rabbit sera specific for the 
granule serine enzymes PR3, NE, CG, and MPO as previously described (42).
To control normal neutrophil differentiation in Prtn3–/–Ela2–/– mice, 
peripheral blood neutrophils were characterized by flow cytometry using 
fluorescently labeled Gr-1– and CD11b-specific antibodies (BD Biosci-
ences — Pharmingen) as previously described (25, 26). Blood smears were 
prepared and stained on glass slides according to the Diff-Quick proto-
col (Dade-Behring), and neutrophil morphology was analyzed by light 
microscopy. Differential blood leukocytes were identified by morphology 
and counted under the microscope to determine the percentage of each 
population. Moreover, the cell count per milliliter blood of each leukocyte 
population was determined using a hemocytometer (improved Neubauer 
chamber). For detailed descriptions of genetic characterization of Prtn3–/–
Ela2–/– mice, see Supplemental Methods.
Recombinant and purified proteins. Recombinant mouse PR3 was produced 
and purified as previously described (43). Human NE was purchased from 
Elastin Products. Recombinant human PGRN was prepared as previously 
described (21). Recombinant mouse PGRN (aa 18–589) was produced with 
an N-terminal S-tag by transient expression into the supernatant of H5 
insect cells using a modified pIEx-5 vector (Novagen; Merck) and the secre-
tion signal of the adipokinetic hormone. Transfection of H5 insect cells cul-
tured in TC-100 medium (Gibco; Invitrogen) was done using the Fugene HD 
transfection reagent (Roche) according to the manufacturer’s instructions. 
At 6 days after transfection, the supernatant was harvested, and recombinant 
mouse PGRN was purified using an S-protein agarose column (Novagen; 
Merck). Following extensive washing of the column with PBS, the bound 
protein was eluted by 3 M magnesium chloride. Immediately thereafter, frac-
tions were dialyzed against PBS and analyzed by silver-stained SDS-PAGE. 
Pure fractions were pooled and dialyzed against 20 mM ammonium bicar-
bonate, lyophilized, and stored at –80°C until use. For experiments, lyophi-
lized protein was reconstituted in sterile PBS (Gibco; Invitrogen).
Skin inflammation models. Croton oil (Sigma-Aldrich) was diluted to 1% in 
acetone, and this dilution was topically applied to the ventral and the dor-
sal sides (20 μl each) of the ears of WT and Prtn3–/–Ela2–/– mice (n = 4 per 
group). After 4 h, mice were sacrificed by CO2 inhalation. The earflap was 
split into 2 halves by carefully separating the dorsal and ventral skin. For his-
tological analysis, dorsal and ventral halves of ears were subjected to whole-
mount immunostaining. After fixation in paraformaldehyde, ear halves 
were blocked with 1% BSA (PAA Laboratories) in PBS for 1 h at room tem-
perature, probed with biotin-labeled anti–Gr-1 (RB6-8C5; BD Biosciences — 
Pharmingen) to identify neutrophil granulocytes and anti–pan-laminin 
(L9393; Sigma-Aldrich) to visualize the EBM, diluted in 1% BSA in PBS over-
night at 4°C (while shaking), and washed with 1% BSA in PBS. Antibodies 
were detected with a repeated cycle of staining with anti-rabbit Alexa Fluor 
488 (Invitrogen) and anti-rat Cy3 (Dianova) before tissue was embedded in 
elvanol and representative images taken with a Zeiss Axio Imager equipped 
with an ApoTome (Zeiss). Location of neutrophils was analyzed in detail for 
potential accumulation at the basement membrane. For quantification of 
neutrophil influx, at least 3 images of the inflamed skin were taken using 
a ×10 objective to quantify total neutrophil infiltrates (calculated as the 
percentage of Gr-1 signal per microscopic field) using Metamorph software 
(Molecular Devices), while intravascular signal was excluded.
The RPA, a widely used model of IC-mediated inflammation, was induced 
in the skin of mice using OVA (grade V; Sigma-Aldrich) as the antigen and 
purified rabbit anti-OVA antibodies of the IgG class (Rockland Immuno-
chemicals Inc.). Initially, the hair was removed from the ventral skin, and 
the area was cleaned with 70% alcohol. Anti-OVA IgG (2 μg/μl) was depos-
ited intradermally in a volume of 30 μl using a 27-gauge needle. Intradermal 
injection of 30 μl unspecific polyclonal rabbit IgG (2 μg/μl; Sigma-Aldrich) 
served as a negative control in the same animal. Without delay, the anti-
gen solution (OVA; 20 mg/kg body weight) was injected i.v. After 4 h, mice 
were sacrificed by CO2 asphyxiation, and the inflammatory response was 
assessed by histology. Paraffin-embedded sections of the specimens were 
processed for H&E staining and analyzed by light microscopy for inflamma-
tory cellular infiltrates. Neutrophils were additionally identified using Gr-1 
immunohistochemistry. Briefly, deparaffinized tissue sections were incu-
Figure 7
Proposed function of PR3 and NE in IC-mediated inflammation. TNF-α– 
primed neutrophils extravasate from blood vessels, translocate PR3/NE 
to the cellular surface, and discharge PGRN to the pericellular envi-
ronment (i). During transmigration of interstitial tissues (ii), neutrophil 
activation is initially suppressed by relatively high pericellular levels of 
antiinflammatory PGRN (green shading), which is also produced local-
ly by keratinocytes and epithelial cells of the skin. Until IC depots are 
reached, neutrophil activation is inhibited by PGRN. Surface receptors 
(e.g., Mac-1) recognize ICs, which results in signal transduction (black 
dotted arrow) and activation of the phox. The molecular pathway of 
PGRN-mediated inhibition is not completely understood, but it may 
interfere with integrin signaling after IC encounter (green dotted line 
inside the cell). Adherence of neutrophils to ICs (iii) further increases 
pericellular PR3 and NE activity. PR3 and NE cooperatively degrade 
PGRN in the early stage of neutrophilic activation to facilitate optimal 
neutrophil activation (red shading), resulting in sustained integrin sig-
naling (red arrow) and robust production of ROS by the phox system. 
Subsequently, neutrophils release ROS together with other proinflam-
matory mediators and chemotactic agents, thereby enhancing the 
recruitment of further neutrophils and establishing inflammation (iv). 
In the absence of PR3/NE, the switch from inflammation-suppressing 
(ii) to inflammation-enhancing (iii) conditions is substantially delayed, 
resulting in diminished inflammation in response to ICs (iv).
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bated with a rat anti–Ly-6G antibody (BD Biosciences — Pharmingen) fol-
lowed by a biotinylated goat anti-rat antibody (BioGenex). Bound antibod-
ies were labeled with streptavidin–alkaline phosphatase and visualized with 
fast red (BioGenex). Sections were counterstained with Mayer hematoxylin 
solution (Merck Eurolab). Random high-power fields (HPFs) of the lesions 
were photographed using a Leica DFC320 CCD camera (Leica) attached to 
a Zeiss Axioplan 2 microscope (Zeiss) with a ×10 objective. Digitized images 
were used to enumerate neutrophils as mean number per HPF in lesions 
from WT (n = 12), Ela2–/– (n = 13), and Prtn3–/–Ela2–/– mice (n = 12).
To study the inhibitory capacity of PGRN on IC-stimulated inflamma-
tion, we deposited 2 μg recombinant mouse PGRN by intradermal injec-
tion together with 30 μl anti-OVA solution as described above. In the same 
mouse at different sites of the ventral skin, we intradermally applied anti-
OVA alone and control IgG as positive and negative controls, respectively. 
The RPA was started by i.v. administration of OVA. Mice were sacrificed 4 h 
after initiation, and biopsies were taken to histologically quantify neutro-
phil infiltrates per HPF in PGRN-treated and untreated lesions from WT 
and Prtn3–/–Ela2–/– mice (n = 5 per group).
Collagen gel chemotaxis assay. For migration assays, PureCol (INAMED) in 
1× MEM (Sigma-Aldrich) and 0.4% sodium bicarbonate (Sigma-Aldrich) 
was mixed with cells in RPMI (Invitrogen) with 10% FCS (Invitrogen) at a 
2:1 ratio, resulting in gels with a collagen concentration of 1.6 mg/ml. Neu-
trophils were primed by 10 ng/ml mouse TNF-α (Roche) for 15 min at 37°C. 
Final cell concentrations in the assay were 1.6 × 106 granulocytes per millili-
ter of gel. Collagen-cell mixtures were cast in custom-made migration cham-
bers with a thickness of 0.5–1.0 mm. At 30 min after the assembly of the col-
lagen fibers at 37°C, the gel surface was covered with 50 μl of 0.1 μg/ml C5a 
solution (R&D Systems). Pictures of migrating cells were taken every 20 s 
using a Zeiss Axioplan 2 light-field microscope (Zeiss), and stacks of images 
were used to generate time-lapse videos in .AVI format using Metamorph 
(Molecular Devices). Chemotactic parameters were calculated and visualized 
as plots by analyzing the acquired data with a Chemotaxis and Migration 
Tool plug-in (http://www.ibidi.de/applications/ap_chemo.html).
Isolation of mouse neutrophils. Mouse neutrophils were purified from the 
bone marrow using a discontinuous percoll gradient (Amersham Bioscience) 
as previously described (44). Neutrophil preparations were characterized by 
Gr-1 and CD11b (Mac-1) double immunostaining using flow cytometry and 
were found to be at least 80% pure. To isolate murine neutrophils ex vivo from 
an inflammatory environment, we injected 1 ml of a 9% sterile casein solution 
in PBS to induce peritonitis. At 4 h after injection, cells were harvested by 
peritoneal lavage using sterile PBS without Ca2+ or Mg2+ (Gibco; Invitrogen). 
Peritoneal cells were layered on a discontinuous histopaque 1119–1077 gradi-
ent (Sigma-Aldrich), and, after centrifugation for 30 min at 700 g, neutrophils 
were isolated from the 1.119–1.077 kg/l interphase. For anti-PGRN Western 
blots and PR3/NE activity assays, neutrophil lysates were prepared. In brief, 
neutrophils were lysed in 50 mM Tris/HCl (pH 7.4), 150 mM NaCl, 0.5 mM 
EDTA, and 0.5% nonidet by mechanical disruption using syringes with 
27-gauge needles. Cell debris was pelleted by centrifugation. All steps were 
carried out at 4°C, and supernatant was frozen until used.
Neutrophil oxidative burst in vitro. To test neutrophil activation by ICs in 
vitro, we prepared immobilized ICs using an OVA/anti-OVA system as 
described previously (20). Isolated neutrophils were resuspended at a den-
sity of 2 × 106 cells/ml in phenol red–free RPMI (Gibco; Invitrogen) con-
taining 10 ng/ml mouse TNF-α (Roche) and added to immobilized ICs. 
Activation by 25 nM PMA (Sigma-Aldrich) without TNF-α served as a 
positive control. We also determined the oxidative burst of neutrophils as a 
function of increasing PMA concentrations (0.1–50 nM) in order to define 
the concentrations that yield submaximal responses in mouse neutrophils. 
ROS production as the readout for neutrophil activation was detected 
using dihydrorhodamine 6G (catalog no. D633; Invitrogen) according to 
the manufacturer’s instructions, and the increase in fluorescence was mea-
sured over time with the fluorometer FLUOstar OPTIMA (BMG Labtech) 
at 37°C. For each time point, the IC-specific oxidative burst was determined 
by subtracting the mean fluorescence read on negative control coating from 
that on IC coating. To compare independent experiments, we normalized 
oxidative burst relative to maximum ROS production by WT neutrophils.
To examine the effect of PGRN on neutrophil activation in vitro, we first 
approximated the concentration of cell-associated and secreted PGRN in 
the absence of PR3/NE during IC-mediated neutrophil stimulation by 
comparison with the positive control band in anti-PGRN Western blot, 
estimated to be approximately 100 nM. We then added recombinant PGRN 
at a final concentration of 100 nM to isolated WT neutrophils stimulated 
by ICs or PMA. We compared the oxidative burst between PGRN-treated 
and untreated cells as described above.
Adhesion assay. Isolated neutrophils were labeled with Calcein AM 
(Invitrogen) and plated on ICs in the presence of 10 ng/ml TNF-α as previ-
ously described (20). In brief, wells were washed with PBS at the indicated 
time points, the number of adhering cells was determined using a fluores-
cence reader, and the percentage was calculated.
Phagocytosis assay. Neutrophil phagocytosis of opsonized, FITC-labeled 
E. coli was determined by flow cytometry using the Phagotest (Orpegen Phar-
ma) according to the manufacturer’s instructions, with some modifications. 
Briefly, 100 μl heparinized blood was incubated with 20 μl FITC-labeled E. coli 
suspension (109 bacteria/ml) and incubated for 30 min at 37°C. After wash-
ing and DNA staining (using DNA staining solution from the Phagotest kit), 
samples were analyzed by flow cytometry. Bacterial aggregates were excluded 
based on their lower DNA content, and neutrophil granulocytes were gated 
in the forward/side scatter analysis. Phagocytosis of FITC-labeled E. coli by 
neutrophil granulocytes was determined using the FL-1 channel regarding 
percentage as well as fluorescence intensity of phagocytosing cells.
Analysis of PGRN degradation. PGRN processing activity was tested with 
recombinant mouse PR3 and human NE each at a molar enzyme/substrate 
ratio of 1:10 according to the buffer conditions described by Zhu et al. (23). 
Recombinant human PGRN (2.5 μg) was added to enzymes and incubated at 
37°C. At the time points indicated in the figures, samples were placed on ice, 
and the pattern of cleavage products was analyzed by reducing SDS-PAGE 
and subsequent silver staining.
To determine whether PGRN-degrading enzymes other than PR3 and 
NE existed in neutrophils, we incubated recombinant mouse PGRN with 
lysates from 3 × 104 WT, Ela2–/–, and Prtn3–/–Ela2–/– neutrophils for 1 h at 
37°C. Samples were separated by SDS-PAGE and transferred onto nitrocel-
lulose membranes. After incubation for 2 h in blocking buffer (5% fat-free 
dry milk in PBS/0.2% Tween-20), mouse PGRN was detected by Western 
blotting with sheep anti-mouse PGRN antibody (R&D Systems) at a con-
centration of 0.4 μg/ml and unspecific sheep IgG as a negative control 
(1 μg/ml; catalog no. I5131; Sigma-Aldrich). Bound antibodies were visual-
ized using peroxidase-conjugated donkey anti-sheep Igs (1:10,000; Jackson 
ImmunoResearch Laboratories) and ECL reagents (Amersham Pharmacia). 
For actin detection, the membranes were incubated in a 1:5,000 dilution 
of anti-actin mouse monoclonal antibody (clone JLA-20; Calbiochem) fol-
lowed by peroxidase-conjugated goat anti-mouse IgG and IgM incubation 
(1:10,000; Pierce) and subsequent ECL detection.
For detection of PGRN from neutrophils activated by ICs in vitro, we 
harvested the supernatant as well as the cellular pellet of isolated TNF-α– 
primed neutrophils after 3 h of IC stimulation. The concentrated super-
natant as well as the cellular pellet of 2 × 105 IC-activated neutrophils was 
separated by reducing SDS-PAGE and subjected to anti-PGRN Western 
blotting as described above.
To analyze whether PGRN was cleaved by PR3/NE during inflammation 
in vivo, we harvested neutrophils from the inflamed peritoneum of WT 
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and Prtn3–/–Ela2–/– mice. Lysates were prepared from these cells as described 
above, but in the presence of 75 μg/ml PMSF and protease inhibitor cock-
tail (Calbiochem). Total lysates from 8 × 105 cells were subjected to anti-
PGRN Western blotting, which was carried out as described above.
Statistics. All results are given as mean and SEM for data derived from 
different in vivo experiments and as mean and SD for data resulting from 
triplicate in vitro assays using isolated cells or cell lysates. Normal distribu-
tion of data sets was determined by the Kolmogorov-Smirnov test before 
we applied an unpaired Student’s t test to compare 2 groups. Calculations 
were done using GraphPad Prism software. A P value less than 0.05 was 
considered statistically significant.
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